Cigna Corp Company Top Insiders

CI Stock  USD 265.30  -4.34  -1.61%   
Under 69% of Cigna Corp's corporate insiders are selling. The analysis of insiders' sentiment of trading Cigna Corp stock suggests that many insiders are alarmed at this time. Cigna Corp employs about 65.7 K people. The company is managed by 50 executives with a total tenure of roughly 269 years, averaging almost 5.0 years of service per executive, having 1313.38 employees per reported executive.
David Cordani  CEO
CEO and President Director and Member of Executive Committee
Isaiah Harris  Chairman
Independent Chairman of the Board
Insider Sentiment 31
 Mostly Selling
 
Selling
 
Buying

Latest Trades

2026-03-02Everett NevilleDisposed 1719 @ 288.91View
2026-01-29Ro KhannaAcquired @ 271.18
2026-01-13Ro KhannaAcquired @ 271.77
2025-12-19Gilbert Ray Cisneros, Jr.Acquired @ 272.11
2025-12-18Julie JohnsonDisposed @ 273.87
2025-11-13Julie JohnsonDisposed @ 270.54
2025-11-12Gilbert Ray Cisneros, Jr.Disposed @ 270.99
2025-11-10Ro KhannaDisposed @ 257.69
2025-11-03David CordaniAcquired 4134 @ 241.88View
2025-10-07Ro KhannaAcquired @ 307.21
2025-10-03Brian C EvankoDisposed 5368 @ 300View
2025-09-29Ro KhannaDisposed @ 286.39
2025-09-25Julie JohnsonDisposed @ 284.06
2025-09-23Val T. HoyleDisposed @ 289.87
2025-09-05Ro KhannaAcquired @ 305.28
2025-08-15Nicole S JonesDisposed 28526 @ 300View
2025-08-14Julie JohnsonDisposed @ 290.55
2025-08-05Gilbert Ray Cisneros, Jr.Disposed @ 271.17
2025-08-04Ro KhannaDisposed @ 267.26
Following insider trading sentiment in Cigna Corp can help investors add context around confidence, timing, and operating risk while the public narrative is still evolving. The signal is still regulated and disclosed under securities law, which is why the public filing record matters more than rumor or interpretation alone.

Acquired vs Disposed

Filed vs Not Filed

The insider-sentiment profile for Cigna Corp is usually inferred from how executives, directors, and beneficial owners buy or sell shares over time. Cigna Corp's insiders buying shares can be interpreted as a constructive signal, while persistent selling may suggest less confidence in the current setup.
Trending Equities provides context for diversified portfolio construction. Such insight adds context to allocation decisions within a diversified portfolio. This reflects a position in Cigna Corp within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
New to investing in Cigna Stock? Start with our How to Invest in Cigna Stock guide for a step-by-step overview.

Cigna Corp's Workforce Through the Years

A workforce review of Cigna Corp matters because hiring and staffing trends often say something about growth plans, cost discipline, and management expectations. Current projections suggest a workforce around under 73800 employees by April 2026, which should be reviewed alongside revenue and margin trends.
 
Covid
 
Interest Hikes

Cigna Corp's latest congressional trading

Trading activity by members of Congress in Cigna Corp is closely watched because transparency, timing, and public trust all matter when elected officials buy or sell public securities. The practical value comes from transparency: investors can compare timing, trade size, and subsequent price action without relying on rumor.
2026-01-16Representative Julie JohnsonAcquired Under $15KVerify
2025-12-12Representative Julie JohnsonAcquired Under $15KVerify
2025-11-14Representative Ro KhannaAcquired Under $15KVerify
2025-10-08Representative Julie JohnsonAcquired Under $15KVerify
2025-10-03Representative Ro KhannaAcquired Under $15KVerify
2025-09-12Representative Valerie HoyleAcquired Under $15KVerify
2025-06-30Representative Jared MoskowitzAcquired Under $15KVerify
2024-01-16Senator Jerry MoranAcquired Under $15KVerify
2020-01-29Representative Gerald E ConnollyAcquired Under $15KVerify
2019-09-03Representative Lois FrankelAcquired Under $15KVerify
2019-04-27Representative Gerald E ConnollyAcquired Under $15KVerify
2019-02-09Representative Alan S LowenthalAcquired Under $15KVerify

Cigna Corp Management Team Effectiveness

The company has Return on Asset (ROA) of 4.09 % which means that for every $100 of assets, it generated a profit of $4.09. This is typical in the industry. Likewise, it shows a return on total equity (ROE) of 15.13 %, which means that it produced $15.13 on every 100 dollars invested by current stockholders.
As of yesterday, Common Stock Shares Outstanding is positioned to expand toward approximately 358.4 M, whereas Net Income Applicable To Common Shares is moving lower toward under 2.8 B.

Cigna Stock Ownership Analysis

About 92.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.72. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cigna Corp has Price/Earnings To Growth (PEG) ratio of 0.55. The entity recorded earning per share (EPS) of 22.19. The firm last dividend was issued on the 5th of March 2026. Cigna Corp completed a 3:1 stock split on 5th of June 2007.
Reviewing share-based compensation in Cigna Corp helps investors understand how management balances employee incentives against dilution risk. Shares outstanding are near 263.5 M. That is why investors should compare compensation intensity with revenue growth, margin progress, and free-cash-flow generation.

Cigna Corp Quarterly Liabilities And Stockholders Equity

157.92 Billion

Cigna Corp Insider Trades History

Reviewing insider ownership in Cigna Corp helps investors understand how much of the equity base is controlled by people involved in running the business. Insiders currently hold about 1.64% of outstanding shares. Investors usually want to know whether that level supports alignment without creating excessive control risk. View all of Cigna Corp's insider trades
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Cigna Stock Institutional Investors

Institutional ownership matters in Cigna Corp because pension funds, mutual funds, banks, and advisers can materially influence liquidity, governance, and price discovery. Used correctly, institutional data helps investors understand who may be setting the marginal price and how resilient that holder base could be under stress.
Shares
T. Rowe Price Investment Management,inc.2025-09-30
3.7 M
Norges Bank2025-12-31
3.7 M
Morgan Stanley - Brokerage Accounts2025-09-30
3.7 M
Capital Research Global Investors2025-09-30
3.2 M
Arrowstreet Capital Limited Partnership2025-12-31
M
Bank Of America Corp2025-09-30
2.8 M
Northern Trust Corp2025-09-30
2.8 M
Ubs Asset Mgmt Americas Inc2025-09-30
2.3 M
Charles Schwab Investment Management Inc2025-12-31
2.2 M
Vanguard Group Inc2025-12-31
26.2 M
Blackrock Inc2025-09-30
22.1 M
A large institutional presence can look reassuring, but sophisticated ownership alone should not be mistaken for proof that a position is mispriced or low risk. Ownership data should therefore support due diligence rather than replace it.

Cigna Corp Insider Trading Activities

Insider trading disclosures for Cigna Corp offer a structured way to watch how people closest to the business are behaving while expectations change across the market. Current market capitalization is about 72.56 Billion. Used properly, these records are better for context than for blind buy-or-sell signals.
 
Everett Neville over a week ago
Insider Trading
 
Everett Neville over two weeks ago
Insider Trading
 
Everett Neville over two weeks ago
Insider Trading
 
Everett Neville over three weeks ago
Insider Trading
 
Everett Neville over three weeks ago
Insider Trading
 
Everett Neville over three weeks ago
Insider Trading
 
Everett Neville over a month ago
Insider Trading
 
Everett Neville over a month ago
Insider Trading
 
Everett Neville over a month ago
Insider Trading
 
Everett Neville over a month ago
Insider Trading
 
Everett Neville over a month ago
Insider Trading
 
Everett Neville over a month ago
Insider Trading

Cigna Corp Outstanding Bonds

Reviewing Cigna Corp bond obligations helps investors understand how much of the business is financed with fixed-income capital rather than purely with equity. This is why bond analysis is not just a credit exercise; it also informs equity holders about solvency, optionality, and future capital-allocation pressure.

Cigna Corp Corporate Filings

13A
5th of March 2026
An amended filing to the original Schedule 13G
ViewVerify
8K
3rd of March 2026
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
27th of February 2026
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
10K
26th of February 2026
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
8K
5th of February 2026
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
2nd of December 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
18th of November 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
5th of November 2025
An amended filing to the original Schedule 13G
ViewVerify
The majority of Cigna Corp's outstanding shares are owned by institutional investors. Institutional investors such as pension funds, mutual funds, and asset managers typically hold large positions as part of their investment mandates, managing money on behalf of clients or beneficiaries. As a result, they are subject to reporting requirements and oversight rules — such as 13F filings and position disclosure thresholds — that do not apply to individual retail investors. Institutional investors hold approximately 92% of Cigna Corp's outstanding shares, with insiders holding 2% and 7% in the public float.
 
Shares in Circulation  
 First Issued
1985-09-30
 Previous Quarter
268.2 M
 Current Value
265.9 M
 Average Shares Outstanding
452.4 M
 Quarterly Volatility
184 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Cigna Stock Holders Distribution

Institutional ownership analysis for Cigna Corp matters because banks, hedge funds, pension plans, and other professional investors can influence price and liquidity more forcefully than smaller holders. This matters because getting in early on a sponsorship cycle may help, but getting caught near a large-holder exit can have the opposite effect.

Cigna Corp Market Cap and Value

Cigna Corp Workforce Comparison

Cigna Corp is rated fifth among stocks in number of employees category among its top compatitors. The total workforce of Health Care industry is currently estimated at about 719,952. Cigna Corp holds roughly 65,669 in number of employees claiming about 9% of equities under Health Care sector.

Cigna Corp Profit Margins

The company has Net Profit Margin (PM) of 0.02 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.04 %, which signifies that for every $100 of sales, it has a net operating income of $0.04.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.08980.0945
Notably Down
Slightly volatile
Net Profit Margin0.02060.0217
Notably Down
Slightly volatile
Operating Profit Margin0.05050.0332
Way Up
Slightly volatile
Pretax Profit Margin0.02620.0276
Notably Down
Slightly volatile

Cigna Corp Insider Trading History

Insider trading disclosures for Cigna Corp offer a structured way to watch how people closest to the business are behaving while expectations change across the market. Current market capitalization is about 72.56 Billion. Used properly, these records are better for context than for blind buy-or-sell signals.
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2026-03-01
1.4
21
15
159,009
29,124
2025-12-01
1.3333
4
3
10,511
11,637
2025-09-01
0.8333
5
6
27,530
56,246
2025-03-01
1.15
23
20
262,606
104,391
2024-12-01
2.0
2
1
224.25
50.00
2024-09-01
0.6
6
10
27,766
59,387
2024-06-01
1.6667
20
12
25,838
42,695
2024-03-01
0.6716
45
67
383,056
379,458
2023-12-01
3.0
3
1
63,570
63,306
2023-09-01
0.65
13
20
25,282
67,408
2023-06-01
4.6667
14
3
8,945
1,651
2023-03-01
0.9302
40
43
375,582
178,308
2022-12-01
0.7273
8
11
25,129
49,407
2022-09-01
0.625
10
16
28,102
66,986
2022-06-01
1.0
29
29
102,859
251,042
2022-03-01
1.2045
53
44
345,487
56,336
2021-12-01
5.0
15
3
44,515
41,005
2021-09-01
5.3333
16
3
14,461
768.00
2021-06-01
0.725
29
40
352,246
644,968
2021-03-01
1.0645
66
62
608,063
424,915
2020-12-01
1.1429
24
21
145,754
284,598
2020-09-01
2.4444
22
9
35,137
31,369
2020-06-01
0.7805
32
41
379,766
676,674
2020-03-01
1.186
51
43
397,256
181,950
2019-12-01
1.5455
17
11
37,452
73,376
2019-09-01
7.0
14
2
36,445
628.00
2019-06-01
4.6667
14
3
7,389
7,394
2019-03-01
1.8182
60
33
390,673
109,918
2018-12-01
3.1818
175
55
3,853,450
713,125
2018-09-01
8.0
8
1
4,382
238.00
2018-06-01
2.6667
8
3
2,730
2,265
2018-03-01
1.2
18
15
83,017
57,036
2017-12-01
4.5
9
2
2,195
1,150
2017-09-01
1.1538
15
13
65,140
127,723
2017-06-01
0.9091
10
11
19,131
55,125
2017-03-01
1.6154
21
13
169,725
88,331
2016-12-01
2.6667
8
3
2,544
6,600
2016-09-01
8.0
8
1
2,674
500.00
2016-06-01
4.0
8
2
2,681
1,542
2016-03-01
2.0
20
10
216,811
90,054
2015-06-01
1.6667
10
6
12,624
29,938
2015-03-01
1.0606
35
33
335,228
305,047
2014-12-01
3.0
9
3
3,774
892.00
2014-09-01
1.2222
11
9
18,550
45,759
2014-06-01
0.8571
24
28
112,421
143,488
2014-03-01
1.75
21
12
279,218
96,415
2013-12-01
1.5
9
6
5,412
8,781
2013-09-01
1.2222
11
9
31,803
67,688
2013-06-01
1.0
17
17
77,140
136,055
2013-03-01
1.3125
21
16
252,350
77,637
2012-12-01
0.7778
14
18
13,912
11,972
2012-09-01
0.9375
15
16
20,392
26,952
2012-06-01
1.0
14
14
18,368
21,064
2012-03-01
1.1667
21
18
156,733
43,309
2011-12-01
0.6364
7
11
19,950
28,977
2011-09-01
0.8
8
10
20,839
26,572
2011-06-01
1.4545
16
11
56,230
29,348
2011-03-01
0.8182
9
11
44,390
15,938
2010-12-01
0.5333
8
15
22,803
39,437
2010-09-01
0.6
6
10
4,375
6,561
2010-06-01
1.1667
14
12
28,176
11,608
2010-03-01
0.7143
10
14
45,078
77,882
2009-12-01
1.0625
17
16
171,752
617,135
2009-09-01
1.2308
16
13
214,387
391,157
2009-06-01
1.3636
15
11
21,581
64,393
2009-03-01
1.3846
18
13
563,383
30,618
2008-12-01
6.0
6
1
20,531
4,730
2008-09-01
0.9
9
10
60,147
35,904
2008-06-01
0.0886
7
79
12,061
51,411
2008-03-01
0.1304
15
115
671,196
298,523
2007-12-01
0.3333
8
24
78,979
127,788
2007-06-01
0.217
23
106
130,161
210,625
2007-03-01
0.413
19
46
269,347
290,904
2006-12-01
0.8571
12
14
127,832
235,356
2006-09-01
1.0
7
7
15,416
30,183
2006-06-01
8.0
8
1
3,821
2,635
2006-03-01
0.7143
20
28
305,621
365,782
2005-12-01
0.6667
10
15
172,290
315,576
2005-09-01
1.1429
16
14
34,703
41,509
2005-06-01
1.1
22
20
67,450
69,231
2005-03-01
0.9375
15
16
387,528
387,043
2004-06-01
2.0
16
8
160,896
177,686
2004-03-01
3.0
9
3
467,958
146,056

Cigna Corp Notable Stakeholders

Stakeholders matter for Cigna Corp because not every influential participant is a shareholder acting with the same objective or time horizon. This becomes more informative when investors want to understand not just ownership, but influence, incentives, and strategic pressure points.
David CordaniCEO and President Director and Member of Executive CommitteeProfile
Timothy WentworthChief Executive Officer - EvernorthProfile
Isaiah HarrisIndependent Chairman of the BoardProfile
Nicole JonesExecutive Vice President, General CounselProfile
John MurabitoExecutive Vice President - Human Resources, Chief Administrative OfficerProfile
Christopher MBAPresident BusinessesProfile
Brian EvankoChief Financial Officer, Executive Vice PresidentProfile
Matt PerlbergPharmacy PresidentProfile
Matthew MandersPresident of U.S. Commercial Markets and Global Health Care OperationsProfile
Noelle EderExecutive Vice President, Global Chief Information OfficerProfile
Eric PalmerChief Financial Officer, Executive Vice PresidentProfile
Dean MirabellaPresident MarketsProfile
Mark BoxerExecutive Vice President, Chief Information OfficerProfile
Adam PharmDPresident ServicesProfile
Jason SadlerPresident of International MarketsProfile
Kristen LauriaExecutive Vice President, Chief Marketing OfficerProfile
Everett NevilleExecutive Vice President, Strategy, Corporate Development and SolutionsProfile
MICHAEL TRIPLETTPresident - U.S. CommercialProfile
Brian CFAPresident HealthcareProfile
Ann DennisonExecutive CFOProfile
Donna ZarconeIndependent DirectorProfile
Eric FossIndependent DirectorProfile
Roman MartinezIndependent DirectorProfile
Kimberly RossIndependent DirectorProfile
John PartridgeIndependent DirectorProfile
Mark McClellanIndependent DirectorProfile
Eric WisemanLead Independent DirectorProfile
George KurianIndependent DirectorProfile
Nicole JDChief VPProfile
John WebbPresident - Health CareProfile
Alexis JonesInvestor PrincipalProfile
Neesha HathiIndependent DirectorProfile
Ralph GiacobbeSenior RelationsProfile
Phil AustinHead MarketsProfile
Elder GrangerIndependent DirectorProfile
Kari StevensExecutive OfficerProfile
Terese CPASenior OfficerProfile
Charles BergPresident - U.S. Government BusinessProfile
Arjan ToorChief OperationsProfile
Durga KokaExecutive OfficerProfile
Cynthia RyanChief Human Resource OfficerProfile
William DeLaneyIndependent DirectorProfile
David KobusMarket MarketProfile
Paul SanfordExecutive Vice President - OperationsProfile
Jamie KatesSenior OfficerProfile
Kathleen MazzarellaIndependent DirectorProfile
Mary CPASenior OfficerProfile
Steven MillerExecutive Vice President Chief Clinical OfficerProfile
Mary PicernoChief OfficerProfile
William RoperIndependent DirectorProfile

Cigna Corp Insider Ownership and Executives

Cigna Corp is a large-cap company in Health Care Providers & Services, Health Care Equipment & Services, Health Care. Executive review focuses on insiders, senior management, and employee signals. Management quality is typically assessed through capital allocation choices and operating follow-through. This analysis reviews how Cigna Corp integrates into a multi-asset portfolio across market cycles.

Methodology

Unless otherwise specified, financial data for Cigna Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Cigna (USA Stocks:CI) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Insider activity and ownership figures are derived from regulatory filings, including SEC Form 4 submissions where applicable.

Assumptions

We use public filings and market reference sources with disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA) as reference inputs. Data may be normalized and can be delayed. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Cigna Corp is covered by 25 analysts. 12 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Citigroup, HSBC Global Research, Stifel, Wells Fargo Securities, UBS Investment Research, RBC Capital Markets, Bank of America Securities, J.P. Morgan, Jefferies, Oppenheimer & Co., among others. Updates may occur throughout the day.

Cigna Corp Workforce Analysis

Investors reviewing Cigna Corp can use workforce efficiency as another lens on execution, especially when comparing similar businesses in the same industry. A disciplined workforce review can reveal whether execution quality is improving beneath the top-line numbers.

Cigna Corp Manpower Efficiency

Return on Cigna Corp Manpower

Revenue Per Employee4.2M
Revenue Per Executive5.5B
Net Income Per Employee95.8K
Net Income Per Executive125.8M

Popular Tools for Cigna Stock analysis

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
FinTech Suite
Use AI to screen and filter profitable investment opportunities